Study to Evaluate Efficacy, Safety and Tolerability of PENNEL Capsule in the Patients With Chronic Liver Disease
Status:
Completed
Trial end date:
1997-10-01
Target enrollment:
Participant gender:
Summary
The test agent in this study is a product of biphenylmethyl dicarboxylate (BDD) with garlic
oil. The two components were confirmed to have complementary effects because of different
operational mechanism in animal experiments, and were examined on humans in this study. Both
BDD and garlic oil are expected to show better protection and treatment on hepatotoxicity
caused by toxic substances, and the purpose of this study is to confirm efficacy of and
safety on human body of the agent and to determine its optimal dose.